Thiakis
Signal active
Organization
Contact Information
Overview
Thiakis Limited with a focus on developing novel medicines for the treatment of obesity and co-morbidities based on original research conducted by Professor Steve Bloom and his colleagues at Imperial College London.
About
Industries
Biotechnology, Life Science
Founded
2004
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Thiakis headquartered in Europe, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $151.7M in funding across 8 round(s). With a team of 1-10 employees, Thiakis is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Thiakis, raised $19.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$19.0M
Details
1
Thiakis has raised a total of $19.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2006 | Early Stage Venture | 19.0M |
Investors
Thiakis is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Novo Ventures | - | FUNDING ROUND - Novo Ventures | 19.0M |
| Raj Parekh | - | FUNDING ROUND - Raj Parekh | 19.0M |
| Thiakis | - | FUNDING ROUND - Thiakis | 19.0M |
| Advent Venture Partners | - | FUNDING ROUND - Advent Venture Partners | 19.0M |
Recent Activity
There is no recent news or activity for this profile.